SUN1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.849200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.371000E-01
Normal-vs-Stage2
3.597800E-01
Normal-vs-Stage3
7.280000E-01
Normal-vs-Stage4
2.272000E-01
Stage1-vs-Stage2
1.402220E-01
Stage1-vs-Stage3
2.822400E-01
Stage1-vs-Stage4
3.057600E-01
Stage2-vs-Stage3
1.661410E-01
Stage2-vs-Stage4
4.133800E-01
Stage3-vs-Stage4
1.430030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.722000E-01
Normal-vs-AfricanAmerican
6.365200E-01
Normal-vs-Asian
4.686000E-01
Caucasian-vs-AfricanAmerican
8.053000E-01
Caucasian-vs-Asian
5.874800E-01
AfricanAmerican-vs-Asian
6.351400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.595600E-01
Normal-vs-Female
4.142400E-01
Male-vs-Female
9.714600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.754800E-01
Normal-vs-Age(41-60Yrs)
1.382210E-01
Normal-vs-Age(61-80Yrs)
4.790200E-01
Normal-vs-Age(81-100Yrs)
6.940400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.659600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.020600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.959000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.174300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.424000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.114000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.062000E-01
Normal-vs-Daily Drinker
4.456800E-01
Normal-vs-Weekly Drinker
4.375000E-01
Normal-vs-Occasional Drinker
1.179160E-01
Normal-vs-Social Drinker
2.789000E-01
Non Drinker-vs-Daily Drinker
4.845200E-01
Non Drinker-vs-Weekly Drinker
6.404200E-01
Non Drinker-vs-Occasional Drinker
5.718500E-03
Non Drinker-vs-Social Drinker
3.607000E-01
Daily Drinker-vs-Weekly Drinker
8.713400E-01
Daily Drinker-vs-Occasional Drinker
7.925600E-02
Daily Drinker-vs-Social Drinker
8.819600E-01
Weekly Drinker-vs-Occasional Drinker
7.578100E-02
Weekly Drinker-vs-Social Drinker
7.430000E-01
Occasional Drinker-vs-Social Drinker
1.068570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.391000E-01
Normal-vs-Grade 2
6.691600E-01
Normal-vs-Grade 3
2.212200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.586200E-01
Grade 1-vs-Grade 3
9.084200E-02
Grade 1-vs-Grade 4
5.391000E-01
Grade 2-vs-Grade 3
1.946760E-01
Grade 2-vs-Grade 4
6.691600E-01
Grade 3-vs-Grade 4
2.212200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.778400E-01
Normal-vs-NonDiabetic
3.080000E-01
Diabetic-vs-NonDiabetic
3.594500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.095840E-01
Normal-vs-NoPancreatitis
4.233600E-01
Pancreatitis-vs-NoPancreatitis
3.037000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.782800E-01
Normal-vs-N1
4.005000E-01
N0-vs-N1
9.650400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.044590E-01
Normal-vs-TP53-NonMutant
5.811400E-01
TP53-Mutant-vs-TP53-NonMutant
1.77255999999071E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
